2000/77/EC: Commission Decision of 17 December 1999 for the purchase by the Community of foot-and-mouth disease antigens and for the formulation, production, bottling and distribution of vaccines against foot-and-mouth disease (notified under document number C(1999) 4683)
Date: 1999-12-17
Institutions: European Commission
Subjects: EU expenditure, animal disease, animal health, foot-and-mouth disease, health expenditure, vaccine

4.2.2000

EN

Official Journal of the European Communities

L 30/35

COMMISSION DECISION

of 17 December 1999

for the purchase by the Community of foot-and-mouth disease antigens and for the formulation,
production, bottling and distribution of vaccines against foot-and-mouth disease

(notified under document number C(1999) 4683)

(2000/77/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), as last amended
by Regulation (EC) No 1258/1999 (2), and in particular Article
14 thereof,

1991

Having regard to Council Decision 91/666/EEC of 11
reserves
December
of
foot-and-mouth disease vaccines (3),
amended by
Council Decision 1999/762/EC (4), and in particular Article 5
thereof,

Community
last
as

establishing

Whereas:

(5) The measures provided for

in this Decision are in
accordance with the opinion of the Standing Veterinary
Committee,

HAS ADOPTED THIS DECISION:

Article 1

The Community shall purchase as soon as possible the

1.
following strains of foot-and-mouth disease antigen:

(cid:151) A Iran 96: 1 000 000 doses,

(cid:151) A Iran 99: 1 000 000 doses,

(1)

In conformity with Decision 91/666/EEC, the purchase of
antigens is a part of the Community action to establish
Community reserves of foot-and-mouth disease vaccines.

(cid:151) A Malaysia 97: 500 000 doses,

(cid:151) SAT1: 500 000 doses,

(2) By Commission Decision 93/590/EC of 5 November 1993
for the purchase by the Community of foot-and-mouth
disease antigens within the framework of the Community
foot-and-mouth disease
action concerning reserves of
vaccines (5), as last amended by Decision 95/471/EC (6),
arrangements were made for purchase of A5, A22 and O1
foot-and-mouth disease antigen.

(cid:151) SAT2 (Southern Africa): 500 000 doses,

(cid:151) SAT2 (East Africa): 500 000 doses,

(cid:151) SAT3: 500 000 doses.

(3) By Commission Decision 97/348/EC of 23 May 1997 for
foot-and-mouth
the purchase by the Community of
the formulation, production,
disease antigens and for
bottling
against
vaccines
and
foot-and-mouth disease (7), arrangements were made for
purchase of A22 Iraq, C1 and ASIA1 foot-and-mouth
disease antigen.

distribution

of

The

Community

for
2.
formulation, production, bottling and distribution of vaccines
against
foot-and-mouth disease produced from antigens
referred to in paragraph 1.

arrangements

shall make

The maximum cost of

3.
paragraphs 1 and 2 shall be up to EUR 2,5 million.

the measures

referred to in

(4) Owing to the disease situation, additional antigens are

required.

The action referred to in paragraph 3 shall be organised

4.
by the Commission before 31 December 1999.

(1) OJ L 224, 18.8.1990, p. 19.
(2) OJ L 160, 26.6.1999, p. 103.
(3) OJ L 368, 31.12.1991, p. 21.
(4) OJ L 301, 24.11.1999, p. 6.
(5) OJ L 280, 13.11.1993, p. 33.
(6) OJ L 269, 11.11.1995, p. 29.
(7) OJ L 148, 6.6.1997, p. 27.

Article 2

The measures mentioned in Article 1(3) shall be carried out by
the Commission in cooperation with the supplier designated
by call for tender.

L 30/36

EN

Official Journal of the European Communities

4.2.2000

Article 3

Article 4

To meet

1.
Commission shall conclude contracts without delay.

the objectives of Articles 1 and 2 the

The Director-General of

2.
for
Health and Consumer Protection shall be authorised to sign
the contracts on behalf of the European Commission.

the Directorate-General

This Decision is addressed to the Member States.

Done at Brussels, 17 December 1999.

For the Commission

David BYRNE

Member of the Commission